These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30019118)
1. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118 [TBL] [Abstract][Full Text] [Related]
2. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination. Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189 [TBL] [Abstract][Full Text] [Related]
3. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143 [TBL] [Abstract][Full Text] [Related]
4. Treatment patterns and associated costs for genital warts in Italy. Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777 [TBL] [Abstract][Full Text] [Related]
5. Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model. Bardach AE; Garay OU; Calderón M; Pichón-Riviére A; Augustovski F; Martí SG; Cortiñas P; Gonzalez M; Naranjo LT; Gomez JA; Caporale JE BMC Public Health; 2017 Feb; 17(1):152. PubMed ID: 28148228 [TBL] [Abstract][Full Text] [Related]
6. [Genital warts and HPV vaccination]. Pilka R; Dvorák V; Fait T Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844 [TBL] [Abstract][Full Text] [Related]
7. Age-based programs for vaccination against HPV. Elbasha EH; Dasbach EJ; Insinga RP; Haupt RM; Barr E Value Health; 2009; 12(5):697-707. PubMed ID: 19490561 [TBL] [Abstract][Full Text] [Related]
8. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination. Perkins RB; Legler A; Hanchate A Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694 [TBL] [Abstract][Full Text] [Related]
9. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687 [TBL] [Abstract][Full Text] [Related]
10. Determining the cost of genital warts: a study from Ireland. Dee A; Howell F; O'Connor C; Cremin S; Hunter K Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863 [TBL] [Abstract][Full Text] [Related]
11. Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland. Ginindza TG; Sartorius B; Dlamini X; Östensson E PLoS One; 2017; 12(5):e0177762. PubMed ID: 28531205 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554 [TBL] [Abstract][Full Text] [Related]
13. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976 [TBL] [Abstract][Full Text] [Related]
14. The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada. Righolt CH; Pabla G; Mahmud SM Appl Health Econ Health Policy; 2018 Apr; 16(2):195-205. PubMed ID: 29299769 [TBL] [Abstract][Full Text] [Related]
15. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis. Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215 [TBL] [Abstract][Full Text] [Related]
16. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]. Monsonégo J; Breugelmans JG; Bouée S; Lafuma A; Bénard S; Rémy V Gynecol Obstet Fertil; 2007 Feb; 35(2):107-13. PubMed ID: 17270482 [TBL] [Abstract][Full Text] [Related]
17. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Hoy T; Singhal PK; Willey VJ; Insinga RP Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749 [TBL] [Abstract][Full Text] [Related]
18. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting. Sharma M; Sy S; Kim JJ BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301 [TBL] [Abstract][Full Text] [Related]
19. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974 [TBL] [Abstract][Full Text] [Related]
20. Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States. Wu CF; Xu L; Fu S; Peng HL; Messick CA; Lairson DR J Manag Care Spec Pharm; 2018 Nov; 24(11):1156-1164. PubMed ID: 30362917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]